We have studied the potency and recovery characteristics of rocuronium during 1.25 MAC of isoflurane, desflurane, sevoflurane or propofol anaesthesia in 84 patients using electromyography. Potency was determined by a cumulative bolus technique. The mean ED 50 of rocuronium was 169 (SD 41), 126 (32), 121 (28) and 136 (25) µg kg -1 during propofol, isoflurane, sevoflurane and desflurane anaesthesia, respectively (ns), and ED 90 values were 358 (62), 288 (29), 289 (28) and 250 (28) µg kg -1 , respectively. The reduction in ED 90 was statistically significant for all three inhalation anaesthetics (PϽ0.05) compared with propofol. After 120 min, the cumulative infusion rate of rocuronium to obtain twitch depression of 90-95% was 9.0 (1.9), 6.3 (1.6), 6.1 (2.0) and 6.1 (1.1) µg kg -1 min -1 during propofol, isoflurane, sevoflurane and desflurane anaesthesia, respectively (PϽ0.01). Recovery index was 22 (13), 27 (10), 28 (13) and 26 (14) min under propofol, isoflurane, sevoflurane and desflurane anaesthesia, respectively (ns). There were no significant differences between the three potent inhalation anaesthetics in relation to potency, infusion requirements or recovery characteristics of rocuronium.
Potent inhalation anaesthetics are known to potentiate the equilibration period of the inhalation anaesthetic. In addineuromuscular blocking effects of benzylisoquinoline 1-3 tion, the infusion rate of neuromuscular blocking drug and aminosteroid 4-11 neuromuscular blocking agents. Halo-required to maintain constant block and recovery characterthane, 6 enflurane 5 6 and isoflurane 5 7 8 and the new agents istics were analysed. desflurane 8 11 and sevoflurane [9] [10] [11] have been shown to enhance the neuromuscular blocking potency of rocuronium, Patients and methods a newer aminosteroid neuromuscular blocking drug. To our After obtaining approval from the Local Ethics Committee knowledge, only one study has compared the interactions and written informed consent, we studied 84 patients of isoflurane, desflurane and sevoflurane with a single dose undergoing major surgery (Table 1 ). This prospective, of rocuronium. 11 A comparative study of the interactions randomized study was performed in close accordance to of the new inhalation anaesthetics and rocuronium after the recommendations of 'good clinical research practice continuous infusion or repeated doses of the neuromuscular (GCRP) in pharmacodynamic studies of neuromuscular blocking drug is lacking. Thus the influence of various blocking agents'. 13 Exclusion criteria were: body weight anaesthetics on the neuromuscular effects of rocuronium more or less than 20% of ideal; patients younger than 18 during and after prolonged anaesthesia is not clear. Furtheryr; expected difficult intubation; pre-existing hepatic, renal more, to quantify the enhancement of the neuromuscular or neuromuscular disease; allergic diathesis; pregnancy block produced by potent inhalation anaesthetics, it is or breastfeeding; and preoperative medications known to important to start the investigation after adequate time has elapsed for inhalation anaesthetics to diffuse into the muscular compartment. 12 †Presented in part at the annual meeting of the German Society of Hence we have compared the influence of propofol, Anaesthesiologists, Hamburg, Germany, April 23-26, 1997 , and at isoflurane, desflurane and sevoflurane on the potency of the annual meeting of the American Society of Anesthesiologists, Orlando, Florida, USA, October 17-21, 1998 rocuronium during steady-state conditions after a 40-min 
Study design
tidal concentration of inhalation anaesthetic was reached, the Relaxograph was re-calibrated and rocuronium 0.1, 0.15 After oral premedication with midazolam 7.5 mg, anaestheor 0.2 mg kg -1 was administered via the central venous sia was induced with fentanyl 3-7 µg kg -1 and propofol line, which was not used for other medications to avoid 2-3 mg kg -1 . Tracheal intubation was performed under precipitation. Maximal depression of the twitch response local anaesthesia without the aid of neuromuscular blocking was recorded to calculate the dose-response curve for agents and anaesthesia was maintained according to a rocuronium. Having recorded maximal depression under computer-generated randomization scheme with propofol stable conditions, a supplementary bolus dose of rocuronium 4-6 mg kg -1 h -1 , isoflurane, desflurane or sevoflurane (1.25 was given so that all patients received a cumulative dose MAC of end-tidal concentration in each instance, ageof rocuronium 0.3 mg kg -1 . After spontaneous recovery of adjusted) supplemented with 60% nitrous oxide in oxygen.
the first response to 5%, a continuous infusion of rocuronium After tracheal intubation, mechanical ventilation of the was started to maintain 90-95% neuromuscular block. lungs was started and a neuromuscular monitor (Relaxo-
The infusion rate of rocuronium needed to produce 90% graph; Datex, Helsinki, Finland) attached to the patient's continuous twitch depression was noted after 30, 60, 90 right arm. and 120 min. After cessation of the infusion, the time
Neuromuscular monitoring
interval to spontaneous recovery to a TOF ratio of 0.7 was recorded. The arm used for neuromuscular monitoring was fixed to an arm board. The ulnar nerve was stimulated transcutane-
Calculations and statistical analysis
ously at the wrist via reference electrodes. Supramaximal stimuli of 0.2 ms duration in a single twitch mode at 0.1 The following variables were calculated: maximum block after the initial and supplementary dose of rocuronium Hz were used for potency estimation and thereafter in a TOF mode at 2 Hz every 15 s until the end of the study. (defined as maximal depression of the twitch response);
time from the end of infusion to spontaneous recovery to The resultant force of contraction of the adductor pollicis muscle was quantified using electromyography (Relaxo-a TOF ratio of 0.25; and time from the end of infusion to spontaneous recovery to a TOF ratio of 0.7. Recovery index graph). Recovery variables were calculated using TOF ratios given on the Relaxograph readout. (This prevented was defined as the time to spontaneous recovery from a TOF ratio of 0.25 to a TOF ratio of 0.7. This was done discrepancies arising if the Relaxograph trace did not recover to control.) according to clinical practice in our institution instead of TOFϭ0.8. 13 The dose-response relationship (mg kg -1 ) was After calibration of the Relaxograph, end-tidal P CO2 was adjusted to 4.3-4.7 kPa (measured by Cicero, Draegerwerke, determined by least squares linear regression of the logarithm of each dose against a probit transformation of the Lubeck, Germany). Core temperature and skin temperature over the thenar muscle were monitored and maintained at initial dose and response of each patient. The effective doses to obtain 50% and 90% neuromuscular block (ED 50 greater than 36.0°C and 32.0°C, respectively, by forced-air warming. Arterial pressure was recorded on the arm that and ED 90 , respectively) were calculated from individual dose-response curves. was not used for evaluation of neuromuscular transmission. Fluids were given via a central venous line or an i.v.
Fisher's exact test, one-way ANOVA, two-tailed t test with Bonferroni's correction, chi-square test and two-way cannula inserted proximal to the area of nerve stimulation. Hypotension was treated with lactated Ringer's solution ANOVA were used, where appropriate, to perform statistical analyses of physical characteristics and pharmacodynamic data. Data are given as mean (SD or range). infusion rate was significantly greater compared with the inhalation anaesthetics (PϽ0.01). There were no significant differences between the potent inhalation anaesthetics. Figure 2 shows the infusion rates of rocuronium required Patient characteristics, type and duration of surgery, and to maintain 90-95% block at 30, 60, 90 and 120 min. end-tidal concentrations of the inhalation anaesthetic are Patients receiving potent inhalation anaesthetics had lower given in Table 1 . There were no significant differences requirements for rocuronium compared with those receiving between groups. During the study, an end-tidal concentration propofol (PϽ0.01). There were no significant differences of 1.25 MAC of the inhalation anaesthetic was maintained between the inhalation anaesthetics. In all groups, the in all patients.
Results
infusion rates were reduced to avoid accumulation of the The mean ED 50 of rocuronium was 169 (SD 41) µg kg -1 neuromuscular blocking agent. Recovery index was 22 (13) during propofol, 126 (32) µg kg -1 during isoflurane, 121 min under propofol, 27 (10) min under isoflurane, 28 (13) (28) µg kg -1 during sevoflurane and 136 (25) µg kg -1 during min under sevoflurane and 26 (14) min under desflurane desflurane anaesthesia (Table 2 ). The reduction in ED 50 of anaesthesia (Table 2 ). There were no significant differences rocuronium by the inhalation anaesthetics was not statistic-between groups. Inter-individual variability of the neuroally significant. In contrast, the ED 90 of rocuronium was muscular response was lowest among patients receiving 358 (62) µg kg -1 under propofol, 288 (29) µg kg -1 under isoflurane anaesthesia. isoflurane, 289 (28) µg kg -1 under sevoflurane and 250 (28) µg kg -1 under desflurane anaesthesia (Table 2 ). This Discussion reduction was statistically significant for all inhalation anaesthetics compared with propofol anaesthesia (PϽ0.05). During steady state conditions, we found that there was a marked interaction between the neuromuscular blocking There were no significant differences between the potency of the inhalation anaesthetics. The groups receiving potent effects of rocuronium and isoflurane, desflurane and sevoflurane, resulting in a leftward shift of the dose-response inhalation anaesthetics showed comparable slopes of the dose-response curves, and the curves were shifted to the curve (Fig. 1) . To maintain 90-95% neuromuscular block, the infusion rate of rocuronium was reduced by 30-40% left (Fig. 1) .
After 120 min, the cumulative infusion rate of rocuronium during isoflurane, desflurane and sevoflurane anaesthesia compared with propofol. to obtain twitch depression of 90-95% was 9.0 (1.9) µg kg -1 min -1 during propofol, 6.3 (1.6) µg kg -1 min -1 during After the age-adjusted end-tidal concentration of the inhalation anaesthetic was reached, another period of 40 min isoflurane, 6.1 (1.1) µg kg -1 min -1 during desflurane and 6.1 (2.0) µg kg -1 min -1 during sevoflurane anaesthesia (see was allowed to elapse before the first dose of rocuronium was given. As tracheal intubation is usually performed after Table 2 ). During propofol anaesthesia, the cumulative only a short period of anaesthesia, it may be of theoretical In clinical practice, the influence of the potent inhalation importance to wait for equilibration of the muscular com-anaesthetics on the infusion rate at which complete neuropartment with the inhalation agent before estimating the muscular block is obtained is important. Our results are in dose-response relationship. However, the duration of action agreement with Shanks, Fragen and Ling, 5 who compared of a neuromuscular blocking drug and the amount needed the infusion rate of rocuronium under balanced, enflurane for maintenance during long operations are affected by the and isoflurane anaesthesia. Under inhalation anaesthesia, type and duration of anaesthesia. Particularly for determina-the infusion rate was reduced by 40%. As in our study, the tion of infusion rate, it is important to study the interactions choice of inhalation anaesthetic had no effect on the between neuromuscular blocking drugs and anaesthetics at total dose of rocuronium required to maintain constant pre-set stable concentrations of inhalation agent. 12 It is neuromuscular block. In another study, isoflurane reduced generally accepted that 40 min is sufficient for equilibration the infusion requirements of rocuronium by 35-40% comof the muscular compartment with volatile anaesthetics pared with various i.v. anaesthetics. 7 The infusion rates which have a high blood-gas coefficient. 12 In clinical of vecuronium also have to be reduced when inhalation practice, intermediate-acting neuromuscular blocking agents anaesthetics are used for maintenance of anaesthesia. 19 are often given repeatedly and not as a single bolus. In our
The time to spontaneous recovery from a TOF ratio of opinion, it is also important to estimate the recovery 0.25 to 0.7 was only slightly, but not significantly, affected variables of these drugs after complete equilibration of the by the presence of potent inhalation anaesthetics in our muscular compartment with the potent inhalation anaesthetic study. Provided that the infusion rate of rocuronium is has been allowed to occur. This opinion has been confirmed adjusted to produce 90% block, the time to complete by two reports on recovery from aminosteroid neuromuscu-recovery during desflurane, sevoflurane and isoflurane lar blocking drugs: in one, time to 25% recovery after a anaesthesia is only slightly prolonged. Compared with single dose of vecuronium was prolonged when the dose isoflurane anaesthesia, the recovery variables were also was given 60 or 120 min after the beginning of anaesthesia slightly, but not significantly, prolonged during desflurane with sevoflurane. 14 In contrast, a 30-min period of stabiliza-anaesthesia in another study in which a single dose of tion did not prolong the time to 25% recovery. In the second rocuronium 0.6 mg kg -1 was given. 8 In a recent study, the study, after rocuronium 0.6 mg kg -1 , recovery indices were recovery index after a single dose of rocuronium was prolonged when 0.8 MAC of isoflurane, desflurane or prolonged during sevoflurane anaesthesia compared with sevoflurane was administered compared with 0.4 MAC. 15 isoflurane or propofol anaesthesia. 10 This may be a result Compared with previous studies, 6 8-11 we found no in part of lack of equilibration of the muscle compartment clinically important differences between the ED 50 and ED 90 as only 10 min of anaesthesia had been allowed to pass of rocuronium under various inhalation anaesthetics. In all before the neuromuscular blocking agent was given. On the studies, the potency of rocuronium was found to be increased other hand, inter-individual variability was found to be by 25-40% under inhalation anaesthesia compared with much higher during sevoflurane anaesthesia in that study. In propofol. The amount of potentiation of the neuromuscular contrast, pancuronium, vecuronium and atracurium showed blocking effect of rocuronium seems to be inversely related comparable prolongation of recovery after sevoflurane and to the MAC of each anaesthetic. This effect has been isoflurane. 18 After continuous infusion of rocuronium for demonstrated for the older inhalation anaesthetics halothane, 120 min, recovery also tended to be prolonged when enflurane and isoflurane. 12 For isoflurane, desflurane and anaesthesia with enflurane or isoflurane was compared with sevoflurane, our results are in accordance with Wulf and barbiturate-nitrous oxide-opioid anaesthesia. 5 In another co-workers. 11 Other groups, however, found lower values study, the recovery index after neuromuscular block profor the ED 50 , but not for the ED 95 , of rocuronium under duced by cisatracurium was prolonged during desflurane isoflurane than under desflurane anaesthesia. 8 Thus the and sevoflurane anaesthesia compared with propofol or amount of potentiation of the neuromuscular blocking isoflurane anaesthesia. 3 Thus recovery during inhalation effect of rocuronium under desflurane anaesthesia remains anaesthesia may be related inversely to analgesic and somewhat unclear as does the degree of potentiation of hypnotic potency, or to blood solubility. This hypothesis, vecuronium under desflurane anaesthesia. Desflurane or however, needs to be proved in further studies. isoflurane 1 MAC was shown to have similar effects on the potency of vecuronium. 16 In contrast, others observed greater potentiation of the neuromuscular effects of vecuron-Acknowledgements ium under desflurane than under isoflurane anaesthesia. 17
